Department of Histology and Embryology, Faculty of Medicine, Cyprus International University, Northern Cyprus via Mersin 10, Turkey.
Faculty of Medicine and Medical Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon; Al Hadi Laboratory and Medical Centre, Beirut, Lebanon.
Reprod Biomed Online. 2024 Aug;49(2):103813. doi: 10.1016/j.rbmo.2024.103813. Epub 2024 Jan 9.
Platelet-rich plasma (PRP) has gained popularity as an experimental tool in regenerative medicine, with potential applications in reproductive medicine. This review will assess the existing literature on the role of PRP in female fertility enhancement, focusing on ovarian rejuvenation and increased endometrial thickness. PRP is being explored as a treatment for recurrent implantation failure, primary ovarian insufficiency and poor ovarian response. While the influence of PRP on endometrial thickness and implantation success is postulated, its effectiveness remains the subject of debate due to protocol variability and unclear patient selection criteria. This narrative review includes 36 articles published before December 2022, and highlights the lack of comprehensive molecular studies examining the impact of PRP on reproductive capacity. This review underscores the importance of standardizing PRP preparation protocols in reproductive medicine. However, challenges persist, and there is a need for well-planned randomized controlled trials and a deeper understanding of the patient population that would gain the greatest benefit from PRP treatment. Clarifying these aspects is crucial to improve outcomes for low-prognosis patients undergoing assisted reproductive technology.
富血小板血浆 (PRP) 作为再生医学中的一种实验工具越来越受欢迎,其在生殖医学中的应用具有潜在的应用前景。本综述将评估 PRP 在增强女性生育能力方面的现有文献,重点关注卵巢年轻化和子宫内膜增厚。PRP 被探索用于治疗复发性着床失败、原发性卵巢功能不全和卵巢反应不良。虽然 PRP 对子宫内膜厚度和着床成功率的影响已被推测,但由于方案变异性和不明确的患者选择标准,其有效性仍存在争议。本综述包括 2022 年 12 月之前发表的 36 篇文章,强调了缺乏全面的分子研究来检查 PRP 对生殖能力的影响。本综述强调了在生殖医学中标准化 PRP 制备方案的重要性。然而,挑战仍然存在,需要精心设计的随机对照试验和对最能从 PRP 治疗中获益的患者人群的更深入了解。澄清这些方面对于改善接受辅助生殖技术的低预后患者的结局至关重要。